Get the Stockscreener App
1.23
4.65%
-0.06
Ovid Therapeutics Inc stock is traded at $1.23, with a volume of 1.48M.
It is down -4.65% in the last 24 hours and up +147.83% over the past month.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
See More
Previous Close:
$1.29
Open:
$1.29
24h Volume:
1.48M
Relative Volume:
0.78
Market Cap:
$87.46M
Revenue:
$391.70K
Net Income/Loss:
$-52.34M
P/E Ratio:
-1.64
EPS:
-0.75
Net Cash Flow:
$-45.92M
1W Performance:
-3.91%
1M Performance:
+147.83%
6M Performance:
+144.82%
1Y Performance:
+7.89%
1-Day Range:
$1.17
$1.33
1-Week Range:
$1.16
$1.34
52-Week Range:
$0.2425
$1.47
Ovid Therapeutics Inc Stock (OVID) Company Profile
Name
Ovid Therapeutics Inc
Sector
Industry
Phone
212-776-4381
Address
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Compare OVID with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OVID
Ovid Therapeutics Inc
|
1.23 | 91.73M | 391.70K | -52.34M | -45.92M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Resumed | B. Riley Securities | Buy |
| Jun-18-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-30-24 | Initiated | B. Riley Securities | Buy |
| Apr-29-24 | Initiated | H.C. Wainwright | Buy |
| Apr-05-24 | Initiated | Wedbush | Outperform |
| Dec-21-23 | Initiated | BTIG Research | Buy |
| Oct-13-23 | Initiated | Oppenheimer | Outperform |
| Apr-20-21 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| Mar-03-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-02-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-04-19 | Initiated | RBC Capital Mkts | Outperform |
| Apr-20-18 | Initiated | Ladenburg Thalmann | Buy |
View All
Ovid Therapeutics Inc Stock (OVID) Latest News
Is Ovid Therapeutics Inc. subject to activist investor interestJuly 2025 Action & Weekly Setup with ROI Potential - خودرو بانک
Can swing trading help recover from Ovid Therapeutics Inc. lossesPortfolio Gains Report & Safe Entry Zone Identification - Newser
Smart tools for monitoring Ovid Therapeutics Inc.’s price actionWeekly Market Outlook & Free Weekly Chart Analysis and Trade Guides - Newser
Real time social sentiment graph for Ovid Therapeutics Inc.July 2025 Macro Moves & Daily Growth Stock Tips - Newser
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
Using Bollinger Bands to evaluate Ovid Therapeutics Inc.2025 Volume Leaders & Community Consensus Trade Signals - Newser
Is Ovid Therapeutics Inc. forming a bottoming basePortfolio Risk Report & Comprehensive Market Scan Insights - Newser
What indicators show strength in Ovid Therapeutics Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Will a bounce in Ovid Therapeutics Inc. offer an exitOptions Play & Step-by-Step Trade Execution Guides - Newser
Can machine learning forecast Ovid Therapeutics Inc. recovery2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
What MACD signals say about Ovid Therapeutics Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - Newser
Using Ichimoku Cloud for Ovid Therapeutics Inc. technicalsPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
How to track smart money flows in Ovid Therapeutics Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser
Why is Ovid Therapeutics Inc. stock going upChart Signals & Community Consensus Trade Alerts - خودرو بانک
Custom watchlist performance reports with Ovid Therapeutics Inc.Stock Surge & AI Driven Price Predictions - Newser
Building trade automation scripts for Ovid Therapeutics Inc.July 2025 Review & High Conviction Investment Ideas - Newser
Will Ovid Therapeutics Inc. price bounce be sustainableM&A Rumor & Fast Entry High Yield Stock Tips - Newser
How hedge fund analytics apply to Ovid Therapeutics Inc. stockBuy Signal & Breakout Confirmation Trade Signals - Newser
What hedge funds are buying Ovid Therapeutics Inc.Weekly Profit Summary & High Accuracy Investment Signals - خودرو بانک
Multi asset correlation models including Ovid Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - Newser
Visualizing Ovid Therapeutics Inc. stock with heatmapsJuly 2025 Final Week & Pattern Based Trade Signal System - Newser
Full technical analysis of Ovid Therapeutics Inc. stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
What recovery options are there for Ovid Therapeutics Inc.Sell Signal & Weekly Return Optimization Plans - Newser
Multi factor analysis applied to Ovid Therapeutics Inc.Market Risk Analysis & Stock Portfolio Risk Management - Newser
Key resistance and support levels for Ovid Therapeutics Inc.2025 Trading Recap & Low Risk High Reward Ideas - Newser
Ovid Therapeutics Reports Increased Revenue Amid Challenges - MSN
Investment Review: Is Ovid Therapeutics Inc. forming a breakout patternJuly 2025 Update & Free Risk Controlled Daily Trade Plans - خودرو بانک
Is it too late to sell Ovid Therapeutics Inc.Weekly Trading Summary & Stock Portfolio Risk Management - Newser
Ovid Therapeutics Inc. stock volume spike explainedTrade Risk Summary & Daily Stock Trend Watchlist - Newser
Analyzing Ovid Therapeutics Inc. with multi timeframe chartsWeekly Profit Analysis & AI Forecasted Stock Moves - Newser
Does Ovid Therapeutics Inc. fit your quant trading modelWeekly Loss Report & Fast Moving Trade Plans - Newser
Quantitative breakdown of Ovid Therapeutics Inc. recent moveRate Cut & Weekly High Potential Stock Alerts - Newser
Ovid Therapeutics Inc. recovery potential after sell offTrade Exit Summary & Weekly High Return Forecasts - Newser
Ovid Therapeutics Inc Stock (OVID) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ovid Therapeutics Inc Stock (OVID) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rona Jeffrey A | CBFO |
Feb 26 '25 |
Sale |
0.56 |
3,902 |
2,185 |
67,973 |
| ALEXANDER MARGARET A. | President and COO |
Jan 27 '25 |
Buy |
0.73 |
6,810 |
4,971 |
34,935 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):